Comment
Author: Admin | 2025-04-28
Drug (e.g., intravenous unfractionated heparin).For adult patients currently taking PRADAXA Capsules wait 12 hours (CrCl ≥ 30 mL/min) or 24 hours (CrCl For pediatric patients currently taking PRADAXA, wait 12 hours after the last dose before switching to a parenteral anticoagulant. Discontinuation for Surgery and Other InterventionsIf possible, discontinue PRADAXA Capsules in adults 1 to 2 days (CrCl ≥ 50 mL/min) or 3 to 5 days (CrCl For pediatric patients, discontinue PRADAXA Capsules 24 hours before an elective surgery (eGFR > 80 mL/min/1.73 m2) or 2 days before an elective surgery (eGFR 50-80 mL/min/1.73 m2). Pediatric patients with an eGFR 2 have not been studied, avoid use of PRADAXA Capsules in these patients.If surgery cannot be delayed, there is an increased risk of bleeding. This risk of bleeding should be weighed against the urgency of intervention. Use a specific reversal agent (idarucizumab) in case of emergency surgery or urgent procedures when reversal of the anticoagulant effect of dabigatran is needed in adults. Efficacy and safety of idarucizumab have not been established in pediatric patients. Refer to the idarucizumab prescribing information for additional information. Restart PRADAXA Capsules as soon as medically appropriate.Frequently asked questionsDoes Feverfew interact with any drugs?Further informationAlways consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.Medical Disclaimer
Add Comment